Financhill
Sell
26

APRE Quote, Financials, Valuation and Earnings

Last price:
$0.91
Seasonality move :
-7.02%
Day range:
$0.91 - $0.94
52-week range:
$0.90 - $5.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.37x
P/B ratio:
0.53x
Volume:
59.6K
Avg. volume:
78.3K
1-year change:
-70.45%
Market cap:
$5.7M
Revenue:
$1.5M
EPS (TTM):
-$2.14

Earnings Data

Next earnings date for APRE
--
Most recent earnings per share
-$0.47
Missed by $0.37
(Nov 7/2025)
Consensus Estimate
-$0.10
(Nov 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

APRE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2025 Q4 -- -- -- -$0.10 --
11/07/2025 Q3 -- $1.8K -$0.47 -$0.10 -$0.37
08/12/2025 Q2 -- $118.1K -$0.53 -$0.71 $0.18
05/14/2025 Q1 -- $162.5K -$0.66 -- --
03/25/2025 Q4 $150K $205.8K -$0.49 -$0.54 $0.05
11/07/2024 Q3 $150K $354.6K -$0.64 -$0.75 $0.11
08/12/2024 Q2 $33.3K $561.6K -$0.58 -$0.61 $0.02
05/14/2024 Q1 -- $380.6K -$0.67 -$0.80 $0.13
03/26/2024 Q4 $100K $14.1K -$0.92 -$0.93 $0.01
11/09/2023 Q3 $83.3K $319.5K -$0.86 -$1.04 $0.18
08/11/2023 Q2 -- $249.7K -$0.87 -- --
05/16/2023 Q1 -- -- -$1.34 -- --
03/15/2023 Q4 -- -- -$18.39 -- --
11/09/2022 Q3 -- -- -$2.32 -- --
08/12/2022 Q2 -- -- -$86.72 -- --
05/16/2022 Q1 -- -- -$7.25 -- --
03/15/2022 Q4 -- -- -$7.18 -- --
11/08/2021 Q3 -- -- -$8.90 -- --
08/12/2021 Q2 -- -- -$9.68 -- --
05/06/2021 Q1 -- -- -$9.13 -- --
03/26/2021 Q4 -- -- -$14.53 -- --
11/05/2020 Q3 -- -- -$11.63 -- --
08/11/2020 Q2 -- -- -$15.51 -- --
05/15/2020 Q1 -- -- -$8.93 -- --
03/26/2020 Q4 -- -- -$12.44 -- --
11/14/2019 Q3 -- -- -$6.03 -- --
06/30/2019 Q2 -- -- -- -- --
03/31/2019 Q1 -- -- -- -- --
12/31/2018 Q4 -- -- -- -- --
09/30/2018 Q3 -- -- -- -- --
06/30/2018 Q2 -- -- -- -- --
03/31/2018 Q1 -- -- -- -- --
12/31/2017 Q4 -- -- -- -- --
09/30/2017 Q3 -- -- -- -- --
06/30/2017 Q2 -- -- -- -- --
03/31/2017 Q1 -- -- -- -- --

Aprea Therapeutics, Inc. Earnings Questions

  • How Much did Aprea Therapeutics, Inc. Generate in Revenue Last Quarter?

    Aprea Therapeutics, Inc. reported $1.8K worth of top line sales in its most recent quarter.

  • Did Aprea Therapeutics, Inc. Beat Earnings Last Quarter?

    Aprea Therapeutics, Inc. announced earnings per share of -$0.47 which represents a miss of analyst forecast a -$0.10 per share.

  • Is Aprea Therapeutics, Inc. Profitable?

    Aprea Therapeutics, Inc. reported -$3.6K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Aprea Therapeutics, Inc. EPS Next Year?

    Aprea Therapeutics, Inc.'s earnings are forecast to decrease from -$2.35 per share to -$2.39 per share next year representing a decrease of -71.51%.

  • When is Aprea Therapeutics, Inc.'s Earnings Date?

    Currently, Aprea Therapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 20, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
55
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
35
SMX alert for Dec 19

SMX (Security Matters) Plc [SMX] is up 24.85% over the past day.

Sell
36
INSP alert for Dec 19

Inspire Medical Systems, Inc. [INSP] is down 19.66% over the past day.

Sell
40
INSM alert for Dec 19

Insmed, Inc. [INSM] is down 16.08% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock